Dexamethasone acetate

Generic Name
Dexamethasone acetate
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C24H31FO6
CAS Number
1177-87-3
Unique Ingredient Identifier
K7V8P532WP
Background

Commonly known as decadron, dexamethasone acetate is a glucocorticosteroid previously marketed in the USA for the treatment of inflammatory respiratory, allergic, autoimmune, and other conditions. Developed in 1957, dexamethasone is structurally similar to other corticosteroids such as hydrocortisone and prednisolone. Dexamethasone acetate has largely been r...

Associated Conditions
Candida Albicans Vulvovaginitis, Dermatitis, Fungal Vaginal Infections
Associated Therapies
Corticosteroid therapy

Dexamethasone for Pain Flare After Radiotherapy of Painful Bone metastasesZonMW 11510009

Phase 3
Completed
Conditions
Interventions
First Posted Date
2012-08-21
Last Posted Date
2016-11-16
Lead Sponsor
UMC Utrecht
Target Recruit Count
411
Registration Number
NCT01669499
Locations
🇳🇱

Leiden University Medical Centre, Leiden, Zuid-Holland, Netherlands

🇳🇱

University Medical Center Utrecht, Utrecht, Netherlands

Single Dose of Dexamethasone in Femur Fractures

First Posted Date
2012-03-09
Last Posted Date
2012-03-09
Lead Sponsor
Cork University Hospital
Target Recruit Count
40
Registration Number
NCT01550146
Locations
🇮🇪

Cork University Hospital, Cork, Ireland

Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

First Posted Date
2011-08-22
Last Posted Date
2015-11-18
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
78
Registration Number
NCT01421173
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Early Treatment With Dexamethasone in Mild Acute Pancreatitis

First Posted Date
2010-11-25
Last Posted Date
2016-12-12
Lead Sponsor
Brigham and Women's Hospital
Registration Number
NCT01247961
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Effects of Steroid Tapering on Functional Capacity and Neurocognition

Not Applicable
Withdrawn
Conditions
Interventions
First Posted Date
2010-07-26
Last Posted Date
2014-05-19
Lead Sponsor
Duke University
Registration Number
NCT01169415

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

First Posted Date
2008-04-02
Last Posted Date
2021-08-18
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
717
Registration Number
NCT00651261
Locations
🇺🇸

St. Luke's Regional Medical Center, Sioux City, Iowa, United States

🇺🇸

Ministry Saint Clare's Hospital, Weston, Wisconsin, United States

🇺🇸

Cancer Centers of the Carolinas - Easley, Easley, South Carolina, United States

and more 173 locations

Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma

First Posted Date
2008-03-13
Last Posted Date
2018-06-07
Lead Sponsor
Mayo Clinic
Target Recruit Count
55
Registration Number
NCT00635154
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2024. All Rights Reserved by MedPath